Parameters of oxidative stress are present in the circulation of PXE patients

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 7-8, 2008, Pages 474-481

  Garcia Fernandez, Maria Inmaculada ^b   Gheduzzi, Dealba ^a   Boraldi, Federica ^a   Paolinelli, Chiara Devincenzi ^a   Sanchez, Purification ^b   Valdivielso, Pedro ^b   Morilla, Maria Josè ^c   Quaglino, Daniela ^a   Guerra, Deanna ^a   Casolari, Sara ^a   Bercovitch, Lionel ^d   Pasquali Ronchetti, Ivonne ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c Hospital of Virgen de la Victoria de Malaga   (Spain)

^d BROWN UNIVERSITY   (United States)

Author keywords

Oxidative stress; Plasma; Pseudoxanthoma elasticum; Redox balance; Serum

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIOXIDANT; LIPID HYDROPEROXIDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; ABCC6 PROTEIN, HUMAN; LIPID PEROXIDE; MULTIDRUG RESISTANCE PROTEIN; SOD3 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PSEUDOXANTHOMA ELASTICUM; ADOLESCENT; BLOOD; CHILD; GENETICS; METABOLISM; MIDDLE AGED; MUTATION;

ADOLESCENT; ADULT; ANTIOXIDANTS; CHILD; FEMALE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; OXIDATIVE STRESS; PSEUDOXANTHOMA ELASTICUM; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE;

EID: 49649088436     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.05.001     Document Type: Article

References (44)

1. Gheduzzi D., Sammarco R., Quaglino D., Terry S., Bercovitch L., and Pasquali-Ronchetti I. Extracutaneous connective tissue alterations in pseudoxanthoma elasticum. Ultrastruct. Pathol. 27 (2003) 375-384
2. Neldner K.H., and Struk B. Pseudoxanthoma elasticum. In: Royce P.M., and Steinmann B. (Eds). Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects (2002), Wiley-Liss, Inc., New York 561-583
3. Gheduzzi D., Guidetti R., Anzivino C., Tarugi P., Di-Leo E., Quaglino D., and Pasquali-Ronchetti I. ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum. Hum. Mutat. 24 (2004) 438-9 and Online Mutation in Brief #755
4. Pfendner E.G., Vanakker O.M., Terry S.F., Vourthis S., McAndrew P.E., McClain M.R., Fratta S., Marais A.S., Hariri S., Coucke P.J., Ramsay M., Viljoen D., Terry P.F., De-Paepe A., Uitto J., and Bercovitch L.G. Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by Pseudoxanthoma elasticum. J. Med. Genet. 44 (2007) 621-628
5. Kool M., van-der-Linden M., deHaas M., Baas F., and Borst P. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer. Res. 59 (1999) 175-182
6. Matsuzaki Y., Nakano A., Jiang Q.J., Pulkkinen L., and Uitto J. Tissue-specific expression of the ABCC6 gene. J. Invest. Dermatol. 125 (2005) 900-905
7. Quaglino D., Boraldi F., Barbieri D., Croce A., Tiozzo R., and Pasquali-Ronchetti I. Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE). Biochim. Biophys. Acta. 1501 (2000) 51-62
8. Quaglino D., Sartor L., Garbisa S., Boraldi F., Croce A., Passi A., DeLuca G., Tiozzo R., and Pasquali-Ronchetti I. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential. Biochim. Biophys. Acta. 1741 (2005) 42-47
9. Passi A., Albertini R., Baccarani-Contri M., DeLuca G., DePaepe A., Pallavicini G., Pasquali-Ronchetti I., and Tiozzo R. Proteoglycan alterations in skin fibroblast cultures from patients affected with Pseudoxanthoma elasticum. Cell. Biochem. Funct. 14 (1996) 111-120
10. Annovazzi L., Viglio S., Gheduzzi D., Pasquali-Ronchetti I., Zanone C., Cetta G., and Iadarola P. High levels of desmosines in urine and plasma of patients with Pseudoxanthoma elasticum. Eur. J. Clin. Invest. 34 (2004) 156-164
11. Maccari F., Gheduzzi D., and Volpi N. Anomalous structure of urinary glycosaminoglycans in patients with Pseudoxanthoma elasticum. Clin. Chem. 49 (2003) 380-388
12. Pasquali-Ronchetti I., Garcia-Fernandez M.I., Boraldi F., Quaglino D., Gheduzzi D., DeVincenzi-Paolinelli C., Tiozzo R., Bergamini S., Ceccarelli D., and Moscatello U. Oxidative stress in fibroblasts from patients with Pseudoxanthoma elasticum: a possible role in the pathogenesis of clinical manifestations. J. Pathol. 208 (2006) 54-61
13. Di-Massimo C., Scarpelli P., Di-Lorenzo N., Caimi G., Di-Orio F., and Ciancarelli M.G. Impaired plasma nitric oxide availability and extracellular superoxide dismutase activity in healthy humans with advancing age. Life Sci. 78 (2006) 1163-1167
14. Marklund S. Extracellular superoxide dismutase. Methods Enzymol. 349 (2002) 74-80
15. Matteucci E., Biasci E., and Giampietro O. Advanced oxidation protein products in plasma: stability during storage and correlation with other clinical characteristics. Acta Diabetol. 38 (2001) 187-189
16. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., and Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49 (1996) 1304-1313
17. Arab K., and Steghens J.P. Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal. Biochem. 325 (2004) 158-163
18. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., and Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. (Colch) 84 (1993) 407-412
19. Halliwell B., Hu M.L., Louie S., Duvall T.R., Tarkington B.K., Motchnik P., and Cross C.E. Interaction of nitrogen dioxide with human plasma. Antioxidant depletion and oxidative damage. FEBS Lett. 313 (1992) 62-66
20. Paoletti F., and Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 186 (1990) 209-220
21. Muller F.L., Lustgarten M.S., Jang Y., Richardson A., and VanRemmen H. Trends in oxidative aging theories. Free Rad. Biol. Med. 43 (2007) 477-503
22. Mitchell G.F., Parise H., Benjamin E.J., Larson M.G., Keyes M.J., Vita J.A., Vasan R.S., and Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women. The Framingham Heart Study, Hypertension 43 (2004) 1239-1245
23. Dröge W. Oxidative stress and aging. Adv. Exp. Med. Biol. 543 (2003) 191-200
24. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
25. Floyd R.A., West M., and Hensley K. Oxidative biochemical markers; clues to understanding aging in long-lived species. Exp. Gerontol. 36 (2001) 619-640
26. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann. N. Y. Acad. Sci. 1067 (2006) 10-21
27. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55 (1998) 1747-1758
28. Iciek M., Chwatko G., Lorenc-Koci E., Bald E., and Wlodek L. Plasma levels of total, free and protein-bound thiols as well as sulfane sulphur in different age groups of rats. Acta Biochim. Pol. 51 (2004) 815-824
29. Di-Simplicio P., Cacace M., Lusini L., Giannerini F., Giustarini D., and Rossi R. Role of protein -SH groups in redox homeostasis - the erythrocytes as a model system. Arch. Biochem. Biophys. 355 (1998) 145-152
30. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., and Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162 (2002) 221-225
31. Nozik-Grayck E., Suliman H.B., and Piantadosi C.A. Extracellular superoxide dismutase. Int. J. Biochem. Cell. Biol. 37 (2005) 2466-2471
32. Juul K., Tybjaerg-Hansen A., Marklund S., Heegaard N.H., Steffensen R., Sillesen H., Jensen G., and Nordestgaard B.G. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City heart study. Circulation 109 (2004) 59-65
33. Olsen D.A., Petersen S.V., Oury T.D., Valnickova Z., Thøgersen I.B., Kristensen T., Bowler R.P., Crapo J.D., and Enghild J.J. The intracellular proteolytic processing of extracellular superoxide dismutase (EC-SOD) is a two-step event. J. Biol. Chem. 279 (2004) 22152-22157
34. Zarbock R., Hendig D., Szliska C., Kleesiek K., and Götting C. Pseudoxanthoma elasticum: genetic variations in antioxidant genes are risk factors for early disease onset. Clin. Chem. 53 (2007) 1734-1740
35. Garibaldi S., Valentini S., Aragno I., Pronzato M.A., Traverso N., and Odetti P. Plasma protein oxidation and antioxidant defense during aging. Int. J. Vitam. Nutr. Res. 71 (2001) 332-338
36. Touyz R.M. Reactive oxygen species; vascular oxidative stress; and redox signaling in hypertension: what is the clinical significance?. Hypertension 44 (2004) 248-252
37. Matsuzaki Y., Nakano A., Jiang Q.J., Pulkkinen L., and Uitto J. Tissue-specific expression of the ABCC6 gene. J. Invest. Dermatol. 125 (2005) 900-905
38. Bonomini F., Tengattini S., Fabiano A., Bianchi R., and Mezzani R. Atherosclerosis and oxidative stress. Histol. Histopathol. 23 (2008) 381-390
39. Gheduzzi D., Boraldi F., Annovi G., DeVincenzi C.P., Schurgers L.J., Vermeer C., Quaglino D., and Pasquali-Ronchetti I. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab. Invest. 87 (2007) 998-1008
40. Baccarani-Contri M., Bacchelli B., Boraldi F., Quaglino D., Taparelli F., Carnevali E., Francomano M.A., Seidenari S., Bettoli V., De-Sanctis V., and Pasquali-Ronchetti I. Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia. J. Am. Acad. Dermatol. 44 (2001) 33-39
41. Aessopos A., Farmakis D., Karagiorga M., Rombos I., and Loucopoulos D. Pseudoxanthoma elasticum lesions and cardiac complications as contributing factors for strokes in beta-thalassemia patients. Stroke 28 (1997) 2421-2424
42. Aessopos A., Farmakis D., and Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta-thalassemia and the sickling syndromes. Blood 99 (2002) 30-35
43. Cighetti G., Duca L., Bortone L., Sala S., Nava I., Fiorelli G., and Cappellini M.D. Oxidative status and malondialdehyde in beta-thalassemia patients. Eur. J. Clin. Invest. 32 (2002) 55-60
44. Tesoriere L., D'Arpa D., Butera D., and Livrea M.A. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients. Free Radic. Res. 34 (2001) 529-540